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Abstract
Bacterial infections occur when the natural host defenses are overwhelmed by invading bacteria. The main component of
the host defense is impaired when neutrophil count or function is too low, putting the host at great risk of developing an
acute infection. In people with intact immune systems, neutrophil count increases during bacterial infection. However, there
are two important clinical cases in which they remain constant: a) in patients with neutropenic-associated conditions, such
as those undergoing chemotherapy at the nadir (the minimum clinically observable neutrophil level); b) in ex vivo
examination of the patient’s neutrophil bactericidal activity. Here we study bacterial population dynamics under fixed
neutrophil levels by mathematical modelling. We show that under reasonable biological assumptions, there are only two
possible scenarios: 1) Bacterial behavior is monostable: it always converges to a stable equilibrium of bacterial concentration
which only depends, in a gradual manner, on the neutrophil level (and not on the initial bacterial level). We call such a
behavior type I dynamics. 2) The bacterial dynamics is bistable for some range of neutrophil levels. We call such a behavior
type II dynamics. In the bistable case (type II), one equilibrium corresponds to a healthy state whereas the other corresponds
to a fulminant bacterial infection. We demonstrate that published data of in vitro Staphylococcus epidermidis bactericidal
experiments are inconsistent with both the type I dynamics and the commonly used linear model and are consistent with
type II dynamics. We argue that type II dynamics is a plausible mechanism for the development of a fulminant infection.
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Introduction
The human body is constantly exposed to bacterial influx from
the environment via the skin, the respiratory tract and the
digestive organs. At the acute stage of bacterial infection, the
neutrophils (phagocytic white blood cells), which make up about
70% of the white-cell blood count in adults, are the main cells that
fight the bacteria. The environmental conditions, neutrophil level
and efficiency of the human barrier tissues play a crucial role in
the susceptibility of the human body to infections [1]. There are
several known medically significant conditions of neutrophils with
reduced number or function that are associated with an increased
risk of infection: patients with severe neutropenia (neutrophil
count less than 500|103 neutrophils/mL in the blood, which is
three to ten times less than the normal values) [2,3]; people
suffering from impaired microbicidal machinery (such as chronic
granulomatous disease-CGD) [4,5]; individuals with neutrophil-
adhesion deficiency (which prevents the neutrophils from leaving
the blood vessels and reaching the site of infection) [6]; individuals
with insufficient vasculature to deliver neutrophils to the site of
infection (e.g. deep burns) [7]. We refer to these medical
conditions as neutropenia-associated conditions. In the medical literature
neutropenia-associated conditions refer to reduced number of
neutrophils and is separated from neutrophils malfunction, here
we bind them together for simplicity of presentation. These full-
body conditions seem to establish the notion that there exists a
critical neutrophil concentration below which the risk of infection
dramatically increases. These observations motivated several
groups to perform in-vitro experiments, with the notion that
characterizing the bacterium-phagocyte dynamics would help
decipher the in-vivo behavior of the innate immune system.
Two views regarding the possible in vitro dynamic behavior of
the bacteria emerged from these experiments. Clawson and
Repine, Leijh et al. and Hammer et al. [8–10] proposed that
bacterial killing by neutrophils is ratio-dependent. In their
experiments, the neutrophil concentration was fixed (2{5:106
neutrophils/mL) and neutrophil-bacteria ratios of 1 : 1 to 1 : 400
were achieved by varying the initial bacterial concentration. On
the other hand, Li et al. [11,12] proposed that there is no ratio
dependency, and that there exists a unique critical neutrophil
value: below this value, the neutrophils cannot control the
bacterial growth at all, regardless of bacterial concentration, and
above this value, the neutrophils can control any bacterial
concentration. They further proposed that the value of this critical
neutrophil concentration can be estimated from a simple linear
mathematical model that is fitted to the experimental data.
This estimated critical value agrees with the commonly accepted
in-vivo critical value for severe neutropenia. Here we further
develop this notion of critical neutrophil concentration and show,
by mathematical considerations, that near this critical value,
non-linear effects cannot be ignored even at small bacteria
concentrations.
Mathematical modelling of the immune system has a long and
rich history, mainly in the context of the adaptive immune
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spatially homogeneous population dynamics are commonly used
(see [13–15] and references therein). Indeed, the model proposed
here, as well as Li et al. [11,12] linear model, belong to the class of
predator-prey models in which the predator population is fixed.
The linear version is just the prey equation of the Lotka-Volterra
system (see e.g., [16, p.79]). Non-linear effects and the natural
emergence of bistability have been widely studied in this context,
see e.g., [17, 18, p.74]. Moreover, it has been observed that
bistability can be experimentally verified by taking advantage of
the hysteresis effect [19–21].
Models for studying the innate immune response in general and
the phagocyte-bacterium interactions in particular, are scarce.
Most studies have concentrated on various in vivo medical
conditions, hence these are inherently of higher dimension, and
always include an equation that describes the bacteria dynamics
coupled to the phagocyte concentrations. Most commonly, the
normal to hyper-response of the phagocytes to the invasion of
bacteria is studied. In Kumar et al., Chow et al. and Reynolds
et al. [22–25], the focus is on the relation between the
inflammatory response, anti-inflammation mediators and sepsis.
In Herald [26], the macrophage dynamics is related to the
development of chronic inflammation after eradication of a
pathogen. In Pugliese and Gandolfi [27], the in-vivo pathogens
and specific and non-specific immunity dynamics are shown to be
potentially quite rich: bistable regions and oscillatory regimes
appear as the model parameters are varied. Imran and Smith [28]
consider the influence of bacterial nutrients on the innate immune
response to bacterial infection and identify locally stable disease-
free region, which is used to design a successful antibiotics
treatment. Finally, models concentrating on in vivo blood-tissue
dynamics showed good fit to experimental data of Escherichia coli
concentration in milk produced from infected cows [29].
Early modelling efforts of bacterium-phagocyte dynamics in
vitro [30,31] focused on probabilistic modelling of the number of
digested particles per neutrophil. These issues were further
explored experimentally, and led to the proposal of a three-
compartment linear ODE model in which the dynamics of viable,
phagocytosed and perforated bacteria are presented [32]. The
works of Li et al. [11,12] were the first to relate the implication of
such experiments and models to the observed in-vivo critical value
of neutrophils.
Notably, in mathematics, as in biology, characterization of a
simplified system (such as an in-vitro experiment) serves as a
building block for more complex systems. The mathematical
building block of Li et al. [11] was utilized in several models of
in-vivo dynamics, e.g., [29,33], whereas others modified this part of
the model and included non-linear and saturation effects (see e.g.
[27]). Thus, our work may be viewed as a careful construction of an
essential building block of more complex systems (see discussion).
Below we briefly describe a class of mathematical models for
bacterial growth when neutrophils are present. We show that non-
linear models that respect elementary robust biological observa-
tions can be divided into exactly two types of behavior that we call
type I and type II. In the Results section, we show that the data in
Li et al. [12] provide experimental evidence that falsifies the
adequacy of the type I and linear behaviors, yet corroborates the
adequacy of type II behavior, (We purposely avoid the word
‘‘validate’’, taking the Popperian [34] view that scientific theories
may only be falsified by experiments). In particular, we show that
the dynamics is not ratio-dependent, and the critical neutrophil
value does depend on the initial bacterial concentration. We
conclude with some observations regarding the clinical implica-
tions of these findings.
Methods
Modelling the Bacterium-Phagocyte Dynamics
To model the bacterial dynamics in a suspension, we write an
ordinary differential equation for the rate of change of the
bacterial concentration B [bacteria/mL], and describe how this
rate depends on the neutrophil concentration N [neutrophils/mL]
and on the external bacterial influx, Infx [bacteria/mL min]. Such
models are adequate for describing well-mixed large population
dynamics. For the clinically relevant values (§104 cells/mL)
stochastic effects may be neglected (see e.g. [35]). Our aim here is
to construct such a model from first principles, so that the
qualitative dynamic consequences will depend only on the
biological assumptions that enter the model and will not depend
on the detailed functional form of the equations.
To this aim, the rate of change of the bacterial concentration is
divided into bacterial birth terms (natural growth and influx) and
death terms (bacterial natural death and killing by neutrophils):
B rate
of change
 !
~
B natural
grow thrate
 !
z
B
influx
 !
{
B
natural death
 !
{
B killing
rate by N
 !
:
Below, we list our assumptions on the form of each of the above
terms. In particular, these considerations imply that each of the
non-constant terms is a monotonic function of B (and the killing
term is also monotone in N). Moreover, we always assume that
the growth/death rates (namely, terms on the right hand side of
the equation divided by B) are saturable as these are controlled by
biological processes that always have a finite maximal rate.
A1. The natural bacterial dynamics (with no neutrophils) has
a limited growth curve.
Namely, by this assumption, the sum of the first two
terms is larger than the third term for BvB
  and the
opposite statement holds for BwB
 , where B
  denotes the
maximal capacity state (also known as the carrying
capacity in the logistic model). Indeed, it is observed that
in well-mixed suspensions, small concentrations of bacteria
grow till they reach high concentrations and then the
density asymptotes to a natural stable equilibrium, the
maximal capacity state. Various mathematical models that
fit experimental growth curves (e.g. logistic, Gomperz, and
saturated growth models such as eq. (1)) satisfy this
assumption (see [36]).
A2. Sufficiently large neutrophil concentrations defeat small
bacterial concentrations.
This assumption presents the minimal requirement for
the ability of neutrophils to control bacteria as observed in
the lab and in the clinic (see e.g. [10]). This assumption
holds for both gram-positive and gram-negative bacterial
strains provided that in the gram-positive case, there is an
ample supply of opsonins [9].
A3. The kill rate increases and is saturable with both B and N.
The monotonicity assumption, namely that the more
neutrophils or bacteria we have, the larger the killing, is
plausible for any killing-term form. The saturability effects
in both B and N (as in the Michaelis-Menten type terms
that appear in predator-prey models with predator
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tion: each neutrophil has a limited killing capacity so the
killing term is saturable in B [9]. At high concentrations of
N (for a fixed Bw0), the availability of bacteria per
neutrophil decreases and thus the killing term is saturable
in N. At limited B values, this assumption is valid for all
bacterium-phagocyte dynamics, see the Discussion section.
A4. The rate of change of B does not depend explicitly on time
or space, or on any other dynamic variable (so in
particular, the neutrophil level N and the B influx Infx
are non-negative constants).
This assumption is reasonable for standard in-vitro
experiments and lab tests in well mixed suspensions for a
limited time scale of about 90 min (so that the neutrophil
function and number are not affected, nor is any other
aspect of the medium that influences the natural bacterial
growth, see e.g. [8,11,39]). The possible applicability of A4
to specific in-vivo situations is a non-trivial issue, see the
Discussion section.
Most of the results described in this paper apply to all models
that satisfy the robust biological assumptions A1–A4. However, for
concreteness and simplicity of presentation, we hereafter consider
the following explicit model:
dB t ðÞ
dt
~
rB t ðÞ
1zbB t ðÞ
zInfx{dB t ðÞ {
a NB t ðÞ
1zcB t ðÞ zgN
: ð1Þ
This model satisfies assumptions A1–A4 for sufficiently small
bacterial influx (0ƒInfx%r=b) provided the six parameters
r,d,b,a,c,g ðÞ are all positive and satisfy rwd (the maximal
capacity here is B
 ~
r{d
bd
) and aw r{d ðÞ g. The first three
parameters govern the natural dynamics of the bacteria: r and d
control the natural linear growth/death rates of the bacteria and b
controls the natural saturation of the bacterial growth rate at high
concentrations (this term reduces to the commonly used logistic
term when bB t ðÞis sufficiently small). The other three parameters
control the killing of the bacteria by the neutrophils: a is the
neutrophils’ bacterial killing rate at low concentrations, and c and
g control the saturation in the killing rate as the concentrations of
B and N are increased (see A3). All of these parameters depend on
both the bacterial strain and the environmental setting: for
example, in an experimental set-up, the serum content and the
form of the toxic clearance affect them. In fact, these parameters
represent global effective responses to a large complex network of
molecular and cellular processes that are associated with the
bacteria natural growth and with the capture and killing of the
bacteria by neutrophils. A calibration of these parameters with
extensive experimental data and with the corresponding molecular
markers may be important for identifying the main effect of these
cellular processes on the bacteria-neutrophil population dynamics
in health and in disease.
This model is non-linear–it takes into account the saturation
effects that appear at high concentrations. If these effects are
neglected, and the influx is set to zero (so b~c~g~Infx~0), we
arrive at the linear model:
dB
dt
~ r{d{aN ðÞ B , (see e.g. [11]).
This linear model has, for all N, only a single equilibrium at the
origin. This fixed point is unstable for small N and stable when
Nw
r{d
a
~N c{lin (as in [11]). Thus, the transient bacterial
dynamics is always independent of the initial bacterial concentration: if
NvN c{lin (respectively NwN c{lin), the bacterial population grows
exponentially without bound (respectively shrinks exponentially to
zero). Moreover, the exponential rate of transient growth/decay of the
bacterial population depends only on the neutrophil concentration: it is
independent of the initial positive concentration of the bacteria.
Notice that this linear model fails to satisfy assumptions A1 and
A3. One may postulate that since saturation occurs only at high
concentrations (near B
 ), the linear model will adequately
describe the dynamics at smaller concentrations. Next, we show
that near N c{lin this postulate is false: the dynamics in the non-
linear and linear models are substantially different, even when B
is small.
Results
Two Possibilities: Robust Dynamics vs. Bistable Dynamics
Mathematical analysis of Eq. (1) shows that depending on the
parameters, one of exactly two types of behaviors, called hereafter
type I and II, can occur (a similar statement can be made for all
models satisfying assumptions A1–A4.).
In the type I parameter regime, the model has no critical
dependence on neutrophil concentration N.T h a ti s ,f o ra l ll e v e l s
of neutrophils there is a single stable equilibrium point (EP)
which depends gradually on N: for low values it corresponds to
the high concentration point associated with the maximal
capacity branch–the branch of stable equilibria that emanates
from the point N, B ðÞ ~ 0, B
  ðÞ ,w h e r eB
  is the maximal
capacity state of the natural bacterial dynamics. As the
neutrophil level increases, this EP gradually lowers till, for
sufficiently high neutrophil level (N§N 1), it reaches the origin
(see Fig. 1a and Models section; for simplicity of presentation, we
consider here the zero influx and show in the Bacterial Influx
section that the results are only slightly modified for small
bacterial influx, see also Fig. 2).
In the type II parameter regime, the model exhibits bistability
for neutrophil concentrations between levels N 1 and N 2 (see
Fig. 1b). For neutrophil levels below N 1, small bacterial
concentrations always grow to the maximal capacity branch.
For neutrophil levels in the range N 1, N 2 ðÞ , the neutrophils can
overcome some portion of the bacterial population but not all of it
(see Fig. 1b). Therefore, in this range, there exists a critical
bacterial concentration, Bc N ðÞ , above which bacterial growth
dominates and below which the neutrophils take control (see
dashed curve in Figs. 1b, 2b). Moreover, in this range the critical
curve Bc N ðÞ is a non-linear increasing function of the neutrophil
count N. Summarizing, N 1 distinguishes between neutrophil
levels that cannot control any non-trivial initial population of the
bacteria and levels that can control a limited size of the initial
bacterial population. A further increase in neutrophil levels
beyond N 2 again leads to robust dynamics by which the
neutrophils can control any size of bacterial population (see
Fig. 1b). This regime, of complete robustness, appears in the ideal
in-vitro setting, where the bacterial natural growth is limited and
the neutrophils concentration and function is kept constant.
Then, very high initial concentrations of bacteria naturally
decrease to the maximal capacity concentration, and so, if there
are enough neutrophils to overcome the maximal capacity, they
indeed defeat any size of bacterial infection. This part of the
dynamics is expected to be usually irrelevant to the in-vivo
dynamics due, for example, to the neutrophil toxicity (see model
limitation section).
To succinctly present the differences between the type I and
type II behaviors, we plot representative bifurcation diagrams
(Fig. 1)– diagrams that show the equilibrium points dependence on
N. It is important to note that these bifurcation diagrams also
Bistability & Bacteria Dynamic
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concentrations in the different regimes. Indeed, the bifurcation
diagrams help us divide the B, N ðÞ plane into regimes of
qualitatively different transient behaviors: regimes in which the
bacterial concentration grows vs. regimes in which it decays.
Notably, such predictions regarding the different transient regimes
may be tested by the standard 90-min bactericidal-phagocyte
experiments (see the Published Data section).
Finally, note that the parameter regimes that determine the resulting
type of behavior depend on the bacterial strain, on neutrophil function
and on the environmental factors (see Models for the exact expression).
For example, by increasing the bacteria’s nutrient supply, the bacterial
dynamics will change from type I behavior under very poor conditions,
to type II dynamics for a sufficientlyrich environment (see Fig. 3 for the
separation of the two behaviors in parameter space).
Notably, only the type II dynamics admits the hysteresis effect;
starting with a neutrophil level N
  in the interval N 1, N 2 ðÞ and a
tiny bacterial population that is under control (representing a
healthy person), a slow decrease in N followed by a slow increase
in neutrophils back to the original value N
  (due, e.g., to a
chemotherapy treatment), may result in subsequent bacterial
growth that may lead to a fulminant infection. The same cycle of
N with the type I dynamics or the linear model will always
eventually result in full recovery. We thus propose that while there
are strains of bacteria exhibiting both types of dynamics in the
body, those that exhibit type II dynamics are the main
Figure 1. The bifurcation diagram: the bacterial equilibrium points (EPs) as a function of neutrophil concentration. Solid line indicates a
branch of stable EPs, and dashed line indicates a branch of unstable EPs. (a) Type I dynamic has a unique stable branch of EPs for all N values. The black
arrows demonstrate that for any positive initial value of the bacteria, for any N, B t ðÞconverges to the corresponding unique stable EP (the intersection
of the solid black curve with a vertical line). Bifurcation diagram is drawn for Eq. (1) with r,d,b,a,c,g ðÞ ~ 10{2,10{3,9:10{9,10{8,10{8,10{10   
: (b)T y p e
II dynamic has a region of bistability: when N[ N 1, N 2 ðÞ , the final state of B depends on whether the initial bacterial concentration is above or below
the critical bacterial curve of unstable EPs (dashed line). The bifurcation diagram is drawn for Eq. (1) with r,d,b,a,c,g ðÞ ~ 10{2,10{3,10{9,
 
10{8,10{8,10{10Þ.( c–d) Time plots of the two initial bacterial concentrations notated by red up and blue down arrows in (b) for a fixed N value (notice
the different time scales).
doi:10.1371/journal.pone.0010010.g001
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next show that type II dynamics indeed appear in nature.
Experimental Evidence for Bistability
Here we analyze the results published by Li et al. [12] of
bactericidal experiments, and show that the published data
correspond to type II bacterial dynamics rather than to type I or
linear dynamics.
Our analysis of the type II model predicts the existence of a
critical bacterial curve, Bc N,Infx ðÞ w0 (dashed branch in Fig. 1b)
at which the rates of growth and killing exactly balance, yet this
balance is unstable. This sensitive dependence of the dynamics on
initial conditions presents the fundamental difference between the
type II behavior and the linear and type I behaviors. This
dependency appears only in the type II parameter regime and only
in the interval N 1, N 2 ðÞ where the critical bacterial curve
separates between initial conditions of bacterial concentrations
that decay towards the stable healthy state (the lower equilibrium
curve) and those that grow towards the infectious state (the upper
equilibrium curve).
We show next that the data of the bactericidal experiments [12]
support the existence of such a critical bacterial curve.
Published Data. In the experiments by Li et al. [11,12],
105{107 neutrophils/mL, and 103{108 CFU/mL of S.
epidermidis bacteria were added into a suspension or a fibrin gel,
simulating human blood and tissue, respectively. The bacterial
level was then recovered from the suspension/gel after 90 min.
Fig. 4a presents the data from Li et al. (Fig. 3b in [12]) in a
different way, namely in the B, N ðÞ plane. Each colored horizontal
dotted line connects the experiments with identical initial bacterial
levels. These horizontal lines are mapped, after 90 min, to the
solid curves of the same color, now connecting the final data points
of the experiments that started with identical initial bacterial
concentration; for clarification, some are emphasized by arrows:
Figure 2. Bifurcation diagrams with zero and small positive bacterial influx. Bifurcation curves for Infx =0, 2:105,4 :105 are shown in black,
magenta and green, respectively. When Infx w0, the bifurcation curves are shifted to the right. (a) Type I: the zero Infx transcritical bifurcation point
at N 1 disappears when Infxw0.( b) Type II: the zero Infx transcritical bifurcation becomes a saddle-node bifurcation that appears at a distance
O
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Infx
b
r
s  !
from the transcritical bifurcation point (see Bacterial Influx). (Insert) A close-up around the transcritical bifurcation of (b). This diagram
shows that under perturbation (Infxw0), the transcritical bifurcation becomes a saddle-node bifurcation.
doi:10.1371/journal.pone.0010010.g002
Figure 3. The natural bacterial parameter space division into type I and type II dynamics. The behavior type is found from the derived
analytical conditions (see Methods) for fixed killing-term parameters as in Fig. 1 (a,c,gÞ~ 10{8,10{8,10{10   
. Notably, most of the parameters give
rise to type II behavior. (a) The r,b ðÞ space is shown for d~10{3.( b) The r,d ðÞ space is shown for b~10{9. The grey region rvd is forbidden, as it
corresponds to a reduction in the bacterial population even with no neutrophils, violating A1.
doi:10.1371/journal.pone.0010010.g003
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(head) for the relevant neutrophil concentration level. When
looking at a fixed B t~0 ðÞ for increasing N values, the arrows (see
e.g. the dotted orange horizontal line and the orange, green, and
two orange arrows in Fig. 4a) decrease in size, till they change
direction, and then they increase again in the opposite direction
(i.e., B t~90 ðÞ is decreasing with the increase in N). From these
two properties (size and direction) we conclude that there is a
curve of ‘‘zero-sized arrows’’, i.e., points of balance between
natural bacterial growth and their killing by neutrophils–these
points belong to the approximated black bold dashed curve in
Fig. 4a. Looking at a fixed N for increasing B t~0 ðÞ values
(vertical direction in Fig. 4a) shows that for low initial bacteria
below the dashed-black curve, the bacterial population is
decreasing (B t~90 ðÞ vB t~0 ðÞ , arrow down) and for high initial
bacteria, above this line, the population is increasing
(B t~90 ðÞ wB t~0 ðÞ , arrow up). This experimentally derived
curve (dashed line in Fig. 4b) corresponds to the predicted
critical bacterial curve Bc N ðÞ (dashed line in Fig. 1b). Thus, the
existence of a positive unstable equilibrium curve Bc N ðÞ for a
range of N values is now established–for the experimental setting
in [12] we now know that 0:5|106,2 |106   
5 N 1,N 2 ðÞ . Such
behavior is consistent with type II dynamics and is inconsistent
with either the linear or type I dynamics. We conclude that the
results presented in Fig. 4a refute the validity of linear and type I
dynamics: in these two cases, one may not change the transient
behavior of the bacteria from decreasing to increasing by elevating
the initial bacterial concentration as occurs at N&1:5|106 (see
green arrows in Fig 3a). These experimental results corroborate
the theoretical prediction that the in-vitro dynamics exhibits a type
II behavior.
Discussion
A model of bacterial dynamics interacting with a constant level
of neutrophils and a constant influx term was constructed. Two
distinct dynamic behaviors, identified as type I and type II,
emerged. In the type II regime, the bacterial dynamics exhibits
bistability for a range of neutrophil levels. We showed that
published experiments do exhibit such bistability, namely that type
II dynamics do appear in in vitro experiments of bacterial growth
under phagocyte attack.
Plausible Clinical Implications
Our modelling effort has two objectives: first, to describe the
dynamics of bacteria interacting with constant levels of neutrophils in
vitro and second, to gain some insights on the role of neutrophil levels
and barrier integrity at the onset of bacterial infection in humans.
We first stress that in vitro studies are clinically important: these
are widely used to estimate neutrophils functionality in patients
with repeated infections (e.g., to diagnose neutropenia-associated
conditions such as the malfunctioning of the neutrophils in CGD
patients [4]). Our findings suggest an additional perspective on
some of the bactericidal tests that are performed in clinical
immunology labs [4]. In these tests, the neutrophil killing
functionality for a given ratio between the bacteria and the
neutrophils (e.g. 1:2 ratio of N : B ðÞ ) is recorded, where
neutrophil function in patients and healthy controls are compared,
and multiple wells are used for quality assurance. The common
wisdom among clinicians is that these tests are unreliable when the
actual concentrations are too low. We can now explain this: at low
concentrations, the tests are probably performed near the critical
bacterial curve, and near this curve very small experimental
inaccuracies can push one well to be above the critical curve and
the other to be below it–leading to substantial deviation in the
results that are thus interpreted as unreliable data. Notably, this
experimental experience again supports the emergence of type II
dynamics in such clinical evaluations: type I behavior does not
support sharp transitions at any given N, and thus predicts small
error bars between different experiments, contrary to the clinical
observations at small concentrations. Thus, we conclude that one
needs to fit a non-linear model (like Eq. (1)) to well-designed
experimental data to decipher the limitations and possible
extensions of these tests. Of note, it is now clear that these in
vitro tests are robust to small measurement errors when the
B, N ðÞ values are far from the critical bacterial curve Bc N ðÞ . The
current protocol of performing these tests at concentrations of
B, N ðÞ & 107,5|106   
indeed satisfies this condition.
Figure 4. Experimental support for the model prediction of bistability. (a) A phase-space presentation of the data from Li et. al. [12]. In this
experiment, neutrophils and S. epidermidis bacteria were added into a gel and the bacteria were recovered after 90 min. The tail of each of the arrows
indicates the bacterial concentration at t~0 and the head indicates the concentration at t~90 min. Dashed colored lines: the initial bacterial
concentrations. Solid colored lines: the corresponding final bacterial concentrations (connecting the corresponding data points). The black bold-
dashed line is the estimated critical curve between neutrophil killing and bacterial growth rate. (b) The type II model (Fig. 1b) bifurcation diagram in
logarithmic scale.
doi:10.1371/journal.pone.0010010.g004
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function in vivo. However, the relation between the in-vitro
bacterial-neutrophil tests and the in-vivo strongly coupled
dynamics is known to be non-trivial. This coupling may lead, for
example, to recovery from an initial state at which the bacterial
concentration is above its critical value by a spontaneous increase
in N. In our axiomatic formulation, such normal in-vivo dynamics
clearly violates assumption A4, and indeed we cannot expect that
any one-dimensional model will adequately describe this interac-
tion. Nonetheless, there are two important implications of our
construction on the in-vivo dynamics: first is the possible direct
clinical implication for patients suffering from neutropenia-
associated conditions as described below, and second, our
construction serves as an important building block for constructing
more realistic models for the common in vivo development of
infections (see Models).
We propose that from a clinical perspective, the model is
relevant to neutropenia-associated conditions, namely, to clinical
situations in which the neutrophil bactericidal functionality is
effectively constant. In each of these conditions (severe neutro-
penia, adhesion or bactericidal malfunction, etc.), the neutrophil
supply from the bone marrow to the infected region is at maximal
capacity, and so the in vivo levels and functionality of the
neutrophils are essentially constant, at least for a few hours,
sometimes for a few days. For example, under severe prolonged
neutropenia, the neutrophil levels are fixed at very low values
(below 500|103 and often in the range of 100|103 cells/mL)
for several days. Moreover, a major cause of this condition are
high-dose chemotherapy treatments that also damage the
mucous. Such chemotherapy treatments increase the bacterial
influx (Infx) and lower the N values in our model. We thus
believe that our model, and in particular assumption A4, may be
relevant for such specific in vivo conditions (see further discussion
in Model Limitations).
Indeed, several clinical findings regarding such patients and the
current recommended treatment strategies are consistent with type
II behavior. First, it is clinically observed that when the white-cell
blood count is low, sterile conditions and isolation, whereby patients
arenot exposedtoanysuddeninfluxofbacteria,dohelpinreducing
the risk of infection [40]. This observation is inconsistent with linear
and type I dynamics, where the development of infection is
independent of the initial bacterial concentration. These observa-
tions are consistent with type II dynamics that predict high
sensitivity to B t~0 ðÞ , especially when N is low and Infxw0,a si s
the case after chemotherapy. Second, it is known that patients
undergoing such treatments are prone to infections and typically
receive antibiotics and sometime G-CSF (growth factor that
promotes neutrophil production) injections. Such treatments
correspond to introducing bacterial death (by antibiotics) and an
increase in neutrophil concentration (by G-CSF) in our model. We
observe that with the current recommended G-CSF injection
schedule,astheneutrophilsrecover fromthenadir,theirlevelshows
an overshoot and only then settles back to normal values (see e.g.,
Fig. 1 in [41]). The need for such an overshoot is consistent only
with type II dynamics due to the hysteresis effect: the chemotherapy
acts as an external force on the neutrophils, causing these to
decrease in number and then increase again to the normal values as
the bone marrow recovers. This loop in the control parameter N
may lead to hysterises effect by which acute infections are developed
even though the neutrophil count is back to normal. A sufficiently
large overshoot (by G-CSF injection or by natural response) is
needed to overcome such a hysterises effect.
We conclude that bistability may be a major cause of bacterial
infection in neutropenic patients, and that further insights may be
drawn from our model. Once the parameters of the model are
calibrated, the effects of antibiotics, non-sterile conditions, and
externally controlled time-dependent neutrophils can be intro-
duced into our model and studied in more details.
Model Limitations
The properties of the model are derived from the axiomatic
biologically motivated assumptions A1–A4 (and are indepen-
dent of the details of the explicit model Eq. (1), see
Mathematical Remarks). While assumptions A1 and A2 seem
to be common to a variety of bacterial strains, assumption A3,
by which the kill rate is monotonic with B,i se x p e c t e dt ob e
more strain-specific; it is expected to be universally true at low
concentrations, but at high concentrations of bacteria strains
that form spatial structures [42] it may fail. For such strains, we
expect to see more complex behavior at these high concentra-
tions (which may still be clinically relevant). Notice that
nonetheless, the division into type I and II behaviors at low
concentrations is still valid.
Assumption A4 is the most restrictive, as it excludes many
important in vivo effects such as time-dependent environmental
variations, coupling to the neutrophil dynamics, coupling to other
bacterial strains and coupling to other systemic feedback
mechanisms of the body. For example, the toxic effect of high
levels of neutrophils and the accompanying feedback mechansims
of anti-inflamatory agents (see e.g. [7,24]) do not enter the model.
Thus, the regime of robust stable dynamics at high neutrophil
concentrations of the in-vitro model (at NwN 2) is likely to be
irrelevant for the in-vivo dynamics when N 2wwN 1. We are
currently expanding our model to include some of these effects.
Nonetheless, we listed several clinically relevant scenarios for
which, for limited time scales, assumptions A1–A4 appear to be
reasonable. In particular, we believe that both the in vitro and in
vivo dynamics in the neutropenic-associated conditions fall into
this category.
In the in vitro setting, these assumptions can be experimentally
tested. It is possible to repeat the experiments of Li et al. [11,12]
with other bacteria and other phagocytes to examine the
universality of our model. Moreover, it is also possible to measure
how the suspension’s content deteriorates with time and how
neutrophil function changes with time. Such experiments can thus
determine the time scale for which this simple model is valid and
provid additional insights regarding the in vivo dynamics (see
Models).
Testing these assumptions in the in vivo settings of neutrope-
nic-associated conditions in humans is clearly more difficult–we
may need to resort to Occam’s razor principle by which the
simplest plausible model is chosen. We did provide some
circumstantial evidence for the plausibility of our model and
the impossibility of the simpler linear model or type I behavior.
Nonetheless, we must point out that even under these restricted
conditions of constant neutrophil number and function, other
dynamic variables (such as macrophages, cytokines, opsonins,
anti-bactericidal factors), spatial effects associated with local
infections (especially in the case of deep burns) and other
temporal effects associated with the full body dynamics (like fever)
may influence the bacterial growth and killing term and thus
violate the A4 assumption. Here, we think of all of these as having
secondary effects; nevertheless it is clear that their impact should
be further studied with a specific neutropenic-associated condi-
tion in mind. Well-designed experiments in animal models may
supply more insights regarding the significance of such effects in a
systematic manner.
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Here we discuss some of the properties of the non-linear model:
we first explain in more detail how we construct the bifurcation
diagrams and what kind of information can be extracted from
them, then we discuss the role of the bacterial influx term
(biologically and mathematically) and finally, we remark on the
generality of our results and on their role as a building block in
higher dimensional models.
Bifurcation Diagrams and Hysteresis
The non-linear model (Eq. (1)) is one-dimensional and has
bounded growth together with first-order elimination. Thus, the
bacterial concentration always settles to some equilibrium point
(EP) of Eq. (1), that is, to a finite B value for which the right hand
side of Eq. (1), which we denote hereafter by f B;N, Infx ðÞ ,
vanishes (see Fig. 1c). In particular, under natural bacterial
dynamics, with no neutrophils or influx (N~0, Infx~0), for any
non-trivial initial concentration, the bacterial growth curve limits
to the maximal capacity, corresponding to the infectious state:
B
 ~
r{d
bd
(thus, we always take rwd). To describe the B
dynamics for general N, we study how the EPs depend on N.
Figs. 1 and 2 present our findings as bifurcation diagrams, showing
how the EP location and stability vary with N. Solid curves in
these figures correspond to stable EPs whereas dashed curves
correspond to unstable ones. The transient dynamics is also shown
in these figures. Since N is constant, the B dynamics occur along
vertical lines in this B, N plane. The direction of motion is
represented in the figures by arrows. Thus, the arrows point
toward stable branches of EPs (solid curves) and away from
unstable branches of EPs (dashed curves) (see Fig. 1c,d for the
corresponding time-flow plot of B t ðÞvs tÞ. The blue-red regions
are marked to stress that the EP branches separate regions for
which the initial bacterial population grows (red) from regions
where it decreases in size (blue).
Moreover, the bifurcation diagrams clearly show the differences
between the type I and type II dynamics: the type I behavior has a
single stable EP for all neutrophil levels. When Infx ~0, this stable
branch of EPs decreases to zero as N is increased beyond N 1. Thus
N 1 is a bifurcation point when Infx ~0; for (NvN 1), the origin is
an unstable EP, at N 1 this unstable branch meets the stable EP
branch that emerges from the maximal capacity value, and at
(N§N 1), the origin becomes a stable EP. When Infxw0, the
origin is no longer an EP, and the stable EP branch simply decays
smoothly towards zero as N increases (mathematically we can say
that the bifurcation point N 1 disappears in a symmetry-breaking
bifurcation). Notice that for small N, the stable branch corresponds
to an infectious state, whereas for large N it corresponds to a
healthy state (which is non-vanishing yet small when Infxw0). In
the type I regime, the transition between a healthy state and an
infectious state as the neutrophil level is changed is gradual.
Moreover, in such a regime, the neutrophils always determine the
eventual state of the bacteria (independent of B t~0 ðÞ ).
The bacterial dynamics in a type II regime (Fig. 1b, 2b) depends
more dramatically on the neutrophil level and, for a range of
neutrophil levels, on the initial bacterial concentration. Here we
have two bifurcation points N 1 Infx ðÞ and N 2 Infx ðÞ , and both
bifurcation points exist for Infx§0 (see below for more details).
For NvN 1 Infx ðÞ , the bacteria always approach the stable EP
that corresponds to high bacterial level (i.e., to an infectious state).
For N 1vNvN 2 there are three EPs forming bistability: the
stable high level infectious state, the stable low level healthy state,
and an intermediate critical unstable state Bc N, Infx ðÞ .I f
B t~0 ðÞ vBc N, Infx ðÞ , then the bacterial level decreases towards
the healthy state, whereas if B t~0 ðÞ wBc N, Infx ðÞ , the bacterial
level increases towards the infectious state. Namely, depending on
the initial infection severity, B may either decrease or increase in
size. When NwN 2 Infx ðÞ , there is one stable solution that
corresponds to a healthy state.
At Infx~0, the model type is determined by the non-linear
stability of the origin (B~0) at the critical neutrophil level
N~N 1: if the EP is non-linearly stable (i.e.,
L
2f
L
2B
0,N 1ƒ0 ð ), the
model is of type I, and it is of type II if the EP is non-linearly
unstable. For sufficiently small Infx, the model type remains the
same as for Infx~0. A small calculation of this non-linear stability
coefficient at N 1~
r{d
a{ r{d ðÞ g
shows that type I appears when
b
c
v 1{
d
r
  
1{
r{d ðÞ g
a
  
, and type II follows when the
inequality is reversed (see Fig. 3). More generally, the appearance
of exactly two types of models at low concentration values is not
accidental: this is the simplest typical behavior for models
satisfying assumptions A1–A4.
The second bifurcation point is located at N 2~
c
b 1zd
r{ 1{d
r ðÞ
dg
a ðÞ {d
r 1z
dg
a ðÞ {2
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It can be shown that B2 is negative in the type I dynamics and
positive in the type II dynamics. If one assumes that
dg
a
vv1,
c
b
d
r
&1, and
c
b
ww
d
r
(as in Fig. 1) the above
expressions simplify to: N 2&
r
a
c
b
1z
d
r
  
{2
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
c
b
{1
r   
,
B2&
ﬃﬃﬃ
r
d
r
{1
    
b. Namely, B2 depends mainly on the natural
bacteria growth curve, whereas N 2 depends mainly on the ratio of
linear growth vs. linear kill and on the saturation rates of the
natural growth vs. the kill term.
Near the critical neutrophil value N 1, the linear model and the
non-linear model at type I and type II regimes provide three
distinct behaviors for low initial bacterial concentrations. Thus, a
careful in vitro experiment near N 1 can distinguish between the
three models.
Note that hysteresis is realized only in the type II dynamics:
starting with a healthy state (such that N 1 Infx ðÞ vNvN 2 Infx ðÞ
and B t~0 ðÞ vBc N, Infx ðÞ is small and under control), the result
of a slow decrease in N below N 1 Infx ðÞ followed by a slow
increase of N to the same initial healthy N value may depend
critically on the manner in which N is varied. If at the end of this
N cycle BfinalwBc N,Infx ðÞ , this state will evolve to a full-blown
infectious state. A further increase in N or other measures, such as
antibiotics (e.g., decreasing r{d), must be applied to avoid the
onset of an acute infection. Note that a similar cycle of N in either
type I regime or in the linear model will always result in a full
recovery to the healthy state with no need for intervention.
Notably, the hysteresis mechanism of the type II dynamic is
robust: small changes in the parameters or even addition of other
small terms to the right hand side of Eq. (1) will shift the
bifurcation points N 1 Infx ðÞ , N 2 Infx ðÞ , but will not destroy them.
Bacterial Influx
While bactericidal activity experiments are performed with no
bacterial influx, such influx is ubiquitous and arises naturally in the in
vivo setting. For example, the digestive system barriers have to fight
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the body [1]. Mathematically, the introduction of a small influx to Eq.
(1) breaks the symmetry of the model, destroying the trivial branch of
equilibrium B~0 and deforming the bifurcation diagrams as shown
in Fig. 2; this deformation is mild for the type I dynamic, but has very
interesting implications for the type II regime, as described next. Most
importantly, note that the main conclusion regarding the zero-influx
model–namely, the existence of bistability for a range of neutrophil
values only in the type II regime, is still valid.
Two interesting features in the type II regime emerge. First, the
unstable branch Bc N, Infx ðÞ moves downward (Figs. 2b, dashed
curves) as the influx is increased. Hence, the interval of initial
bacterial concentration in which the bacteria are under control
shrinks (for a fixed neutrophil concentration in the bistable range).
This suggests that if the neutrophil level is kept constant and there
is an increase in bacterial influx, the susceptibility of the patient to
an acute infection increases. In fact, this happens in cemotheraphy
patients, where the neutrophils are fixed at the nadir (due to the
impact of the treatment on the bone marrow) and the influx is
increased (due to the impact of the treatment on the barriers) [40].
Second, the influx shift of the critical neutrophil level is abrupt
(Fig. 2b-insert)–the bifurcation point N 1 Infx ðÞ is given by
N 1 Infx ðÞ ~
r{d
a{ r{d ðÞ g
zO
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Infx
b
r
s  !
, and the corresponding
critical bacterial level is proportional to
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Infx
b
r
s
(provided that
Infxvv
r
b
&107 bacteria
mL:min
  
for the figure parameters, with r{1
taken as the time scale and b
{1 as the bacterial scale).
Biologically, this implies that near sterile conditions (Infx~0),
tiny changes in the bacterial influx lead to dramatic changes in the
critical neutrophil value that is needed to overcome the tiniest
infection; a fourfold decrease in Infx leads to only a twofold
decrease in the influx-shift of the critical neutrophil levels and to a
twofold decrease in the observed bacterial concentration near
criticality. The effect of such sensitivity on the onset of infection is
expected to be especially dramatic when the neutrophils are at low
counts, near the critical value N 1 Infx ðÞ .
Mathematically, this singular dependence on Infx is a result of
the symmetry breaking, changing the bifurcation point from
transcritical to a saddle-node bifurcation. In fact, assumption A3
implies that this is the only possibility, and that this property is
independent of the details of the explicit model.
Some Mathematical Remarks
Are there other possible models to consider for the one-
dimensional bacterial dynamics? It is possible to show that under
assumptions A1–A4, the type I and II behaviors are the simplest
possible. Other models that satisfy A1–A4 may exhibit regimes in
which additional multi-stability branches at high bacterial
concentrations emerge. Nevertheless, below a certain bacterial
concentration, all robust models that satisfy A1–A4 must exhibit
either type I or type II behavior. For example, if we replace the
natural bacteria dynamic part of the model (
rB
1zbB
{dB) with
e.g., the logistic, (B r{dB ðÞ ), or Gompertz [36] terms, the model
will result in the same qualitative dynamics.
Finally, from a mathematical perspective, at low bacterial
concentrations, the division into the type I and II regimes (namely
the existence of the unstable positive branch Bc N, Infx ðÞ in
regime II and its disappearance in regime I) appears whenever the
coefficient of the quadratic term (B
2) in the Taylor expansion of
f B;N, Infx ðÞ near B~0 at the bifurcation point N 1 changes sign
as the parameters are varied. Thus, in particular, models with a kill
term that has no saturation in N (i.e., no predator interference
term, violating part of assumption A3, as in [27]), or even models
for which the bacteria’s natural dynamics is not limited yet has
some non-linear components (violating A1), can still exhibit the
type I and type II dichotomy at low concentrations. For example,
if we take in model (1) g~0 and r{d ðÞ ,a,c,bw0, we still get the
division into the two regimes. If we further set b~0, we get only
the type II regime. The reasoning for stating assumptions A1–A4 is
thus not mathematical–these are biologically driven assumptions
that are reformulated in mathematical terms.
Some Mathematical Remarks Regarding the In Vivo
Dynamics
The characterization of the principles governing the in vitro
bacterium-neutrophil dynamics may be viewed as a careful
examination of a building block to be utilized in other higher
dimensional models that describe various aspects of the in vivo
dynamics. Indeed, all of the population type models (that neglect
spatial and stochastic effects) for the in vivo dynamics include an
equation which describes how the rate of change in the bacterial
concentration depends on the bacterial concentration, on the
phagocyte concentration and, possibly, on other factors that enter
the model (see e.g. [24,26,43]). Thus, the model presented here
may serve as a solid building block for these more complex models
that are often derived in a phenomenological fashion. In
particular, it is now established that bistability of the bacterial
dynamics arises in nature. Thus, multidimensional models that are
built upon this bistable building block and therefore exhibit rich
dynamics (e.g. [27]) now have concrete reasoning for introducing
this ingredient.
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